| 44972-8 |
Edema site |
Find |
{Body site} |
Pt |
Nom |
|
|
ACTIVE |
Edema site |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
44972-8 |
|
|
|
|
Observation |
|
|
|
0 |
Edema site |
|
|
|
N |
|
bod; Bodies; Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; Random |
2.29 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 44973-6 |
QRS duration |
Time |
{Electrocardiograph lead} |
Pt |
Qn |
|
|
ACTIVE |
QRS duration {Electrocardiograph lead} |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
44973-6 |
|
|
|
|
Observation |
|
|
|
0 |
QRS dur {EKG lead} |
|
|
|
N |
|
{EKG lead}; Cardio; Cardiology; Durat; ECG; EKG; EKG.MEASUREMENTS; Electrocardiogram; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.17 |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 44974-4 |
Arterial pulse intensity |
Force |
{Artery} |
Pt |
Ord |
Palpation |
|
ACTIVE |
Pulse intensity of Unspecified artery palpation |
|
MIN |
DefinitionDescription |
|
|
|
Absent, 1+, 2+, 3+, 4+ |
|
|
|
|
|
H&P.PX |
|
44974-4 |
|
Palpation |
|
|
Observation |
|
|
|
0 |
Pulse intensity Palpation |
|
|
|
N |
|
Art; Cardio; Cardiology; H+P; H+P.PX; Heart Disease; Mechanical force; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.38 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 44975-1 |
QT interval |
Time |
{Electrocardiograph lead} |
Pt |
Qn |
|
|
ACTIVE |
Q-T interval {Electrocardiograph lead} |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
44975-1 |
|
|
|
|
Observation |
|
|
|
0 |
Q-T interval {EKG lead} |
|
|
|
N |
|
{EKG lead}; Cardio; Cardiology; ECG; EKG; EKG.MEASUREMENTS; Electrocardiogram; Heart Disease; Point in time; QNT; Q-T interval; Quan; Quant; Quantitative; Random |
2.48 |
2.17 |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 44976-9 |
PR interval |
Time |
{Electrocardiograph lead} |
Pt |
Qn |
|
|
ACTIVE |
P-R Interval {Electrocardiograph lead} |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
44976-9 |
|
|
|
|
Observation |
|
|
|
0 |
P-R interval {EKG lead} |
|
|
|
N |
|
{EKG lead}; Cardio; Cardiology; ECG; EKG; EKG.MEASUREMENTS; Electrocardiogram; Heart Disease; Point in time; P-R interval; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.17 |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 44977-7 |
Chlamydophila psittaci Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydophila psittaci IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44977-7 |
|
|
|
|
Both |
|
|
|
0 |
C psittaci IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Enzootic abortion of ewes; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Ornithosis; Ovine chlamydiosis; Point in time; PR; Psittacosis; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44978-5 |
Chlamydophila psittaci Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydophila psittaci IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44978-5 |
|
|
|
|
Both |
|
|
|
0 |
C psittaci IgA Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Enzootic abortion of ewes; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Ornithosis; Ovine chlamydiosis; Point in time; PR; Psittacosis; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44979-3 |
Chlamydophila pneumoniae Ab^2nd specimen |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44979-3 |
|
|
|
|
Both |
|
|
|
0 |
C pneum Ab sp2 Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; Convalescent; CPN; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; Serum; sp2; Spec; SR; Twar agent |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4498-2 |
Complement C4 |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Complement C4 [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L;mg/dL |
|
|
|
|
|
|
HEM/BC |
|
4498-2 |
|
|
|
|
Both |
|
|
|
0 |
C4 SerPl-mCnc |
|
|
|
Y |
|
Beta 1 E-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
253 |
| 44980-1 |
Chlamydophila pneumoniae Ab^1st specimen |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydophila pneumoniae Ab [Presence] in Serum --1st specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44980-1 |
|
|
|
|
Both |
|
|
|
0 |
C pneum Ab sp1 Ser Ql |
|
|
|
N |
|
ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; Pre immunization; QL; Qual; Qualitative; Random; Screen; Serum; sp1; Spec; SR; Twar agent |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44981-9 |
Chlamydophila pneumoniae Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydophila pneumoniae IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44981-9 |
|
|
|
|
Both |
|
|
|
0 |
C pneum IgG Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Twar agent |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44982-7 |
Chlamydophila pneumoniae Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydophila pneumoniae IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44982-7 |
|
|
|
|
Both |
|
|
|
0 |
C pneum IgA Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Twar agent |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44983-5 |
Chlamydia trachomatis L2 Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis L2 IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44983-5 |
|
|
|
|
Both |
|
|
|
0 |
C trach L2 IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L2; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44984-3 |
Chlamydia trachomatis L2 Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis L2 IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44984-3 |
|
|
|
|
Both |
|
|
|
0 |
C trach L2 IgG Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L2; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44985-0 |
Chlamydia trachomatis L2 Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis L2 IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44985-0 |
|
|
|
|
Both |
|
|
|
0 |
C trach L2 IgA Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L2; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44986-8 |
Chlamydia trachomatis G+F+K Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis G+F+K IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44986-8 |
|
|
|
|
Both |
|
|
|
0 |
C trach G+F+K IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach G+F+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type G+F+K; CT; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Intermediate; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44987-6 |
Chlamydia trachomatis G+F+K Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis G+F+K IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44987-6 |
|
|
|
|
Both |
|
|
|
0 |
C trach G+F+K IgA Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach G+F+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type G+F+K; CT; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Intermediate; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44988-4 |
Chlamydia trachomatis D+K Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis D+K IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44988-4 |
|
|
|
|
Both |
|
|
|
0 |
C trach D+K IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach D; C trach D+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT D and K; Dextro; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44989-2 |
Chlamydia trachomatis D+K Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis D+K IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44989-2 |
|
|
|
|
Both |
|
|
|
0 |
C trach D+K IgG Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach D; C trach D+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT D and K; Dextro; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4499-0 |
Complement C4 activated |
- |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Complement C4a [Mass/volume] in Plasma |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
4499-0 |
|
|
|
|
|
|
|
|
0 |
Deprecated C4 activated Ser Qn |
|
|
|
|
|
Activ; Beta 1 E-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.66 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 44990-0 |
Chlamydia trachomatis D+K Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis D+K IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44990-0 |
|
|
|
|
Both |
|
|
|
0 |
C trach D+K IgA Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach D; C trach D+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT D and K; Dextro; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44991-8 |
Chlamydia trachomatis C Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis C IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44991-8 |
|
|
|
|
Both |
|
|
|
0 |
C trach C IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44992-6 |
Chlamydia trachomatis C Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis C IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44992-6 |
|
|
|
|
Both |
|
|
|
0 |
C trach C IgG Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44993-4 |
Chlamydia trachomatis C Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis C IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44993-4 |
|
|
|
|
Both |
|
|
|
0 |
C trach C IgA Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44994-2 |
Chlamydia trachomatis B Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Chlamydia trachomatis B IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44994-2 |
|
|
|
|
Both |
|
|
|
0 |
C trach B IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach B; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type B; CT; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Trachoma |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
